Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

600624.SS Net Margin

The Net Margin of Shanghai Fudan Forward S&T Co Ltd (600624.SS) is 0.88%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

600624.SS Net Margin - Historical Value
Date Value
2023-12-31 0.88%
2022-12-31 -0.79%
2021-12-31 -10.12%
2020-12-31 -5.93%
2019-12-31 3.96%
2018-12-31 4.25%
2017-12-31 5.78%
2016-12-31 5.69%
2015-12-31 7.27%
2014-12-31 4.02%
600624.SS Net Margin - Peers Comparison
Ticker Name Value
002550.SZ Changzhou Qianhong Biopharma Co Ltd 23.33%
003020.SZ Hefei Lifeon Pharmaceutical Co Ltd 10.58%
603590.SS Beijing Konruns Pharmaceutical Co Ltd 16.35%
605177.SS Zhejiang East Asia Pharmaceutical Co Ltd 8.94%
000915.SZ Shandong WIT Dyne Health Co Ltd 24.16%
002923.SZ Zhuhai Rundu Pharmaceutical Co Ltd 3.37%
300181.SZ Zhejiang Jolly Pharmaceutical Co Ltd 19.70%
300110.SZ Huaren Pharmaceutical Co Ltd -101.13%
603538.SS Ningbo Menovo Pharmaceutical Co Ltd 4.87%
300705.SZ Hunan Jiudian Pharmaceutical Co Ltd 17.48%
603669.SS Lionco Pharmaceutical Group Co Ltd -34.43%
688189.SS Hunan Nucien Pharmaceutical Co Ltd 0.50%
000908.SZ Hunan Jingfeng Pharmaceutical Co Ltd -32.75%
002118.SZ Jilin Zixin Pharmaceutical Industrial Co Ltd -828.71%
002349.SZ Jinghua Pharmaceutical Group Co Ltd 15.17%
603222.SS Chimin Health Management Co Ltd -7.70%
002365.SZ Qianjiang Yongan Pharmaceutical Co Ltd 7.36%
002940.SZ Zhejiang Anglikang Pharmaceutical Co Ltd 5.22%
300006.SZ Chongqing Lummy Pharmaceutical Co Ltd -11.04%
600222.SS Henan Taloph Pharmaceutical Stock Co Ltd 2.60%
688513.SS Chengdu Easton Biopharmaceuticals Co Ltd 20.28%
600851.SS Shanghai Haixin Group Co Ltd 18.97%
002393.SZ Tianjin Lisheng Pharmaceutical Co Ltd 13.81%
002688.SZ Jinhe Biotechnology Co Ltd 3.98%
300434.SZ Sichuan Goldstone Asia Pharmaceutical Inc 8.32%
002107.SZ Shandong Wohua Pharmaceutical Co Ltd 6.46%
002907.SZ Chongqing Pharscin Pharmaceutical Co Ltd 9.90%
300039.SZ Shanghai Kaibao Pharmaceutical Co Ltd 25.49%